Table 4 Analysis of histological, molecular and therapeutic predictors of survival.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Relative risk (95% CI) | p Value | Relative risk (95% CI) | p Value | |
| Istology | ||||
| Adenoid cystic carcinoma | 1 | – | 1 | – |
| Adenocarcinoma | 0.5 (0.25 to 1) | NS | 0.4 (0.31 to 1.12) | NS |
| Mucoepidermoid/squamous cell carcinoma | 0.333 (0.108 to 1.03) | NS | 0.5 (0.56 to 0.18) | NS |
| TUNEL >6% | 0.244 (0.69 to 0.871) | 0.003 | 0.99 (0.56 to 1.78) | NS |
| Bcl‐2 >6% | 3.850 (1.3 to 14.378) | 0.0015 | 2.1 (1.67 to 12.56) | 0.011 |
| p53<10% | 4.950 (1.89 to 16.6) | 0.001 | 1.87 (1.2 to 2.23) | 0.05 |
| Therapy (surgery + radiotherapy) | 0.943 (0.48 to 1.85) | 0.872 | 0.78 (0.44 to 1.89) | NS |